
Symphogen announces new capital raise and explores strategic options 15 May 2019
Today, Symphogen called for an ordinary shareholders meeting to be held on 29 May 2019. At the meeting,... Read more
Today, Symphogen called for an ordinary shareholders meeting to be held on 29 May 2019. At the meeting,... Read more
NEW YORK, May 14, 2019 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)... Read more
The Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) joins the Global Biofoundries... Read more
The big Chinese fine chemical company Zhejiang NHU invest €5.5 M in the biotech start-up CysBio to... Read more
COPENHAGEN, Denmark — 12 March 2019: Acesion Pharma (“Acesion” or the Company), a Danish biotech... Read more
Oslo, Norway, 13 February, 2019 Vaccibody AS, a clinical stage immuno-oncology company, announced today... Read more
Oslo, 14 February 2019 Reference is made to the press release by Vaccibody AS (“Vaccibody”... Read more
NEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)... Read more
MinervaX, a privately held Danish biotech company, announces today that is has been awarded an in... Read more